Zacks Research Predicts Weaker Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Analysts at Zacks Research decreased their Q1 2025 earnings per share estimates for shares of DENTSPLY SIRONA in a research report issued on Thursday, March 20th. Zacks Research analyst I. Bandyopadhyay now expects that the medical instruments supplier will earn $0.31 per share for the quarter, down from their previous forecast of $0.42. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.81 EPS, Q1 2026 earnings at $0.34 EPS, Q2 2026 earnings at $0.48 EPS, Q3 2026 earnings at $0.49 EPS, Q4 2026 earnings at $0.58 EPS, FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.19 EPS.

Several other research firms have also recently weighed in on XRAY. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Evercore ISI restated an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Mizuho dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a report on Thursday, March 13th. Twelve analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $23.33.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $15.56 on Monday. The business has a 50-day simple moving average of $17.92 and a 200-day simple moving average of $20.47. The company has a market cap of $3.10 billion, a PE ratio of -7.52, a P/E/G ratio of 1.80 and a beta of 0.98. DENTSPLY SIRONA has a one year low of $14.78 and a one year high of $33.42. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently bought and sold shares of XRAY. Riverview Trust Co acquired a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth $26,000. Colonial Trust Co SC purchased a new position in DENTSPLY SIRONA during the fourth quarter worth about $26,000. MassMutual Private Wealth & Trust FSB lifted its position in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares during the period. UMB Bank n.a. boosted its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its position in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 1,568 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.11%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.